Wernicke-Korsakoff syndrome pathophysiology

Revision as of 16:09, 29 January 2013 by Kalsang Dolma (talk | contribs) (→‎Microscopic Pathology)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Wernicke-Korsakoff Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wernicke-Korsakoff Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wernicke-Korsakoff syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wernicke-Korsakoff syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wernicke-Korsakoff syndrome pathophysiology

CDC on Wernicke-Korsakoff syndrome pathophysiology

Wernicke-Korsakoff syndrome pathophysiology in the news

Blogs on Wernicke-Korsakoff syndrome pathophysiology

Directions to Hospitals Treating Wernicke-Korsakoff syndrome

Risk calculators and risk factors for Wernicke-Korsakoff syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Aditya Govindavarjhulla, M.B.B.S. [3]

Pathophysiology

Wernicke-Korsakoff syndrome results from thiamin deficiency. It is generally agreed that Wernicke's encephalpathy results from severe acute deficiency of thiamine (Vitamin B1), whilst Korsakoff's psychosis results from chronic deficiency of thiamin. The metabolically active form of thiamine is thiamine diphosphate which plays a major role as a cofactor in glucose metabolism. The enzymes which are dependent on thiamin diphosphate are associated with the TCA Cycle and catalyse the oxidation of pyruvate,alphaketoglutarate and branched chain amino acids. Thus, anything that encourages glucose metabolism will exacerbate an existing clinical or sub-clinical thiamine deficiency. When Wernicke's encephalopathy accompanies Korsakoff's syndrome, the combination is called the Wernicke-Korsakoff syndrome. Korsakoff's is a continuum of Wernicke's encephalopathy, though a recognised episode of Wernicke's is not always obvious.

There is an unreplicated study that has associated susceptiblity to this syndrome with a hereditary deficiency of transketolase, an enzyme involved in thiamine metabolism.[1]

Gross Pathology

Wernicke-Korsakoff syndrome in alcoholics especially is associated with atrophy[2] of specific regions of the brain, especially the mamillary bodies. Other regions include the anterior region of the thalamus (accounting for amnesic symptoms), the medial dorsal thalamus, the basal forebrain, and median and dorsal raphe nuclei.[3]

Microscopic Pathology

Korsakoff's involves neuronal loss, that is, damage to neurons; gliosis which is a result of damage to supporting cells of the central nervous system; and hemorrhage or bleeding in mammillary bodies. Damage to the dorsomedial nucleus of the thalamus is also associated with this disorder. Frequently, for unknown reasons, patients with Korsakoff's psychosis will exhibit marked degeneration of the mamillary bodies. The mechanism of this degeneration is unknown, but it supports current neurological theory that the mamillary bodies play a role in various memory circuit within the brain. An example of a memory circuit is the Papez circuit.

References

  1. Nixon P, Kaczmarek M, Tate J, Kerr R, Price J (1984). "An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff syndrome". Eur J Clin Invest. 14 (4): 278–81. PMID 6434322.
  2. Kolb & Whishaw: Fundamentals of Human Neuropsychology, 2003, pages 473-473
  3. Mann K, Agartz I, Harper C, Shoaf S; et al. (2001). "Neuroimaging in alcoholism: ethanol and brain damage". Alcohol Clin Exp Res. 25 (5 Suppl ISBRA): 104S–109S. PMID 11391058.

Template:WikiDoc Sources